Report #2826334

Overview

Sex

Male

Age

Age unknown

State

NJ

Recovered

Unknown

Vaccinated

—

Onset

—

Days to onset

—

Hospital days

—

Symptoms (1)

Symptom narrative

had a dose of boostrix approximately 6 months earlier; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a male patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. Previously administered products included Boostrix (Patient received a dose approximately six months ago). On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced drug dose administration interval too short (Verbatim: had a dose of boostrix approximately 6 months earlier). The outcome of the drug dose administration interval too short was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 16-JAN-2025 The Health Care Professional was the reporter. The patient received a dose of Boostrix after having had a dose of Boostrix approximately 6 months earlier which drug dose administration interval too short. No further information is known including date vaccine was administered